Geneva is quietly preparing for a fundamental reshape of global health governance. The United States officially withdrew from the World Health Organization last month, leaving a $2.1 billion annual contribution gap. China has signalled its willingness to increase its own funding commitments, positioning itself as the likely successor to American leadership at the Geneva-based body.
The US Departure and Its Financial Fallout
The withdrawal, formally completed on January 22, ends nearly eight decades of American participation in the UN health agency. Under the Trump administration's America First framework, Washington argued the WHO had become too politically influenced and mishandled the COVID-19 pandemic. The exit eliminates roughly 22 percent of the WHO's assessed contributions, the mandatory fees that fund core operations including disease surveillance, emergency response teams, and vaccine programmes across 194 member states.
WHO Director-General Tedros Adhanom Ghebreyesus confirmed the financial impact in a letter to member states obtained by Reuters. "We are working to identify contingency measures," he wrote. "The scale of the shortfall requires urgent action from all parties willing to step forward."
Beijing Signals Readiness to Act
Chinese Foreign Minister Wang Yi announced at the UN General Assembly last September that Beijing would increase its voluntary contributions to the WHO by 30 percent over the next three years. That pledge, worth approximately $300 million annually, has taken on new weight following America's exit.
China's Permanent Mission to the UN in Geneva declined to confirm whether Beijing would seek a formal leadership role in the organisation's executive committee. A spokesperson told reporters only that "China consistently supports the WHO's vital work and will continue to play a constructive role."
Strategic Investments in Global Health
Since 2019, China has channelled more than $800 million into WHO voluntary programmes, primarily focused on maternal health initiatives in Africa and disease prevention projects across Southeast Asia. Those investments, critics argue, have come with implicit expectations of diplomatic goodwill and reduced scrutiny of Beijing's health policies, particularly regarding transparency during disease outbreaks.
The United States, meanwhile, has maintained its bilateral health assistance programmes outside the WHO framework, providing roughly $4 billion annually through USAID and the CDC. Health advocates warn that parallel systems risk fragmenting global disease surveillance and creating dangerous gaps in outbreak detection.
Vanuatu Speaks for Pacific Island Nations
Pacific island nations are watching the power shift with particular concern. Vanuatu's Ambassador to the UN in Geneva, Kal Vau, told a meeting of small island developing states last week that his nation relies heavily on WHO technical support for health system strengthening. "We cannot afford political competition to interfere with the programmes that protect our people," he said. "Whether Washington or Beijing leads, our communities need reliable, neutral support."
Fiji, the Solomon Islands, and Papua New Guinea have all signed joint health cooperation agreements with China over the past five years. Those deals include significant infrastructure components, including hospital construction and medical equipment donations, alongside traditional WHO-supported programmes. The overlapping investments reflect a broader competition for influence across the Pacific.
Washington's Parallel Path
The State Department has established a new Office of Global Health Security, staffed by former USAID officials, to coordinate American health engagement outside the WHO framework. Officials insist the arrangement allows the US to maintain health partnerships while avoiding what one senior official described as "institutional capture by any single country."
Republican lawmakers have broadly supported the withdrawal, arguing the move saves American taxpayers $500 million annually and removes leverage from a body they view as deferential to China. Democratic critics have warned the decision weakens American influence precisely when competitors are expanding theirs.
Geneva Braces for a Changed Institution
European member states, who collectively contribute 35 percent of WHO assessed contributions, are examining whether they can increase their own contributions to offset the American shortfall. Sweden and Germany have signalled openness to larger payments, though that would require parliamentary approval in both countries.
The WHO's executive board is scheduled to convene in February for its annual review of the organisation's programme budget. Several diplomats told reporters the agenda has been rewritten to prioritise financial sustainability planning over programmatic expansion, a direct consequence of the funding uncertainty.
What Comes Next
The WHO's World Health Assembly meets in May in Geneva. That gathering, the organisation's supreme decision-making body, will elect a new chair of its executive board. Traditionally, the position rotates between regional groups, with the current cycle favouring candidates from the Western Pacific region. China's candidacy for a more prominent advisory role is expected to be formalised before that meeting.
Health experts and diplomats will be watching to see whether Beijing frames its expanded role as a temporary bridge while others step up, or as a permanent shift in the institution's power structure. The outcome will shape global health governance for decades, particularly in how the organisation responds to future pandemics and manages relations with major powers simultaneously competing for influence.
Those deals include significant infrastructure components, including hospital construction and medical equipment donations, alongside traditional WHO-supported programmes. The overlapping investments reflect a broader competition for influence across the Pacific.Washington's Parallel PathThe State Department has established a new Office of Global Health Security, staffed by former USAID officials, to coordinate American health engagement outside the WHO framework.
